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ABSTRACT
Autosomal dominant polycystic kidney disease (ADPKD) is one of most common inherited renal diseases. It is estimated 
that very early onset ADPKD affects even 2% patients. The purpose of this article is to provide a comprehensive review of 
genetics, prenatal diagnosis and prognosis in very early onset autosomal dominant polycystic kidney disease.
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INTRODUCTION
Autosomal dominant polycystic kidney disease (ADPKD) 
is one of the most common hereditary kidney diseases. The 
incidence rate is estimated at 1/500–1000 live births. Typi-
cally, the symptoms develop in the age range from 20 to 
50 [1]. It is estimated that an early manifestation of the 
disease (before 15 years of age) is observed in 2% of patients 
[2]. The development of prenatal ultrasound has led to more 
frequent diagnosis of an intrauterine form of ADPKD [3].
AUTOSOMAL DOMINANT POLYCYSTIC 
KIDNEY DISEASE
The clinical picture of ADPKD consists of kidneys enlarged 
by numerous cysts. These cysts may be present in other or-
gans, such as the liver, the pancreas, a lung, and the arachnoid 
mater. This congenital disease can be accompanied by other 
anomalies, such as: intracranial aneurysms, thoracic aortic an-
eurysms and impaired function of the heart valves. Typically, 
extreme renal failure develops around 60 years of age [4, 5].
GENETICS
The basis of this disorder is a mutation of PKD-1, PKD-2, 
or PKD-3 protein-coding polycystine 1 or polycystine 2. 
PKD-1 gene is responsible for 85% of cases of ADPKD and 
it is located on the short arm of chromosome 16 (16p13.3). 
PKD-2 gene is located on the long arm of chromosome 4 
(4q21), while PKD gene-3 has not been mapped yet [6, 7]. 
ADPKD is a disorder inherited in an autosomal dominant 
fashion. The risk of inheriting this mutation is at the level 
of 50%. An early onset of this disease is more common when 
the mother of the child is afflicted by the disease, and when 
the child is a female [8, 9]. However, Hammond denies that 
this disorder has any correlation with gender [10]. The oc-
currence of early-onset ADPKD significantly increases the 
risk of recurrence of the disease, with a similar manifestation, 
in subsequent pregnancies [1]. 
ADPKD is characterized by heterogeneity of the clinical 
picture both between families and “within-family”. There are 
many theories explaining such a diversity. One hypothesis 
explaining this phenomenon is the theory of spontaneous 
mutations — arising de novo or superimposed on an existing 
ones, giving new mutations. It is estimated that up to 10% of 
patients experience spontaneous mutations. It is believed 
that early-onset ADPKD is a result of those mutations [8, 11]. 
Another theory is associated with the presence of hypo-
morphic mutation of PKD1 inherited in trans configuration 
[12–14]. Bergmann notes the relationship of the disease 
with the mutation of the HNF1B gene [15]. In addition, 
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syndromes (e.g. Beckwith-Wiedemann syndrome, Jeune syn-
drome, Lujan-Fryns syndrome, Zellweger syndrome, Trisomy 
18). The first step in the differential diagnosis should be the 
exclusion of other defects of the urinary tract. Subsequently, 
it is crucial to look for additional anomalies of the fetus. The 
presence of coexisting anomalies is more characteristic of 
genetic syndromes, while an isolated kidney disease may 
be a sign of polycystic kidney disease (PKD) [9, 18]. 
The literature describes cases of fetuses, which were diag-
nosed in utero with ADPKD based on ultrasound imaging and 
a positive family history. After birth, these children presented 
a picture of normal kidneys with proper function [10, 22]. 
ADPKD symptoms usually do not appear until adult-
hood and kidney failure progresses subacutely; therefore, 
up to 60% of future parents do not know they are affected. 
Upon diagnosis of the fetus with PKD, parents and even 
grandparents should be examined for this disorder if there 
is an absence of a family history [8]. 
It is particularly important to determine whether ADPKD 
has been inherited from the mother, since hypertension in 
pregnant woman with ADPKD is associated with a high risk 
of feto-maternal complications and require close monitor-
ing and a possible treatment to prevent development of 
pre-eclampsia [23]. 
Prenatal magnetic resonance imaging is a comple-
mentary diagnostic tool for diagnosis of congenital kidney 
anomalies [24]. It is a particularly useful analysis in case of 
oligohydramnios, as an alternative to evaluation of fetal 
anatomy after diagnostic amnioinfusion [25]. Figure 2 shows 
maternal and fetal kidneys with ADPKD. Figure 3 present 
a sagittal view of a fetus with ADPKD.
Using magnetic diffusion resonance (diffusion weighted 
MR, DW-MR) is also possible to assess the renal function. The 
DW–MR technique involves the diffusion process (chaotic mo-
this disease can sometimes be inherited in an autosomal 
recessive fashion [16]. 
There are several genetic tests that can be used to detect 
ADPKD. In most cases, the diagnosis is technically difficult 
and expensive due to the heterogeneity of gene mutation 
for polycysteine (a variety of point mutations: nonsense, 
missense, shifting the reading frame) [11, 17]. Application of 
genetic testing may be considered in asymptomatic patients 
with a family history and for pre-implantation diagnostics. 
PRENATAL DIAGNOSIS
In 2004, Brun et al. described an ultrasound image pat-
tern of kidneys that could suggest ADPKD. Fetal kidneys are 
slightly increased (1 to 2SD), with hyperechogenic cortex 
and hypoechogenic kidney core, resulting in increased di-
versity of cortico-spinal fluid. Amniotic fluid index is within 
the norms. Cysts in the kidneys may be present, but usually 
they do not appear until after birth [18]. The cases previously 
reported in the literature show a similar picture of fetal 
kidneys during an ultrasound examination [4, 8, 19–21]. 
Figure 1 shows an ultrasound image of fetal kidneys with 
ADPKD. An ultrasound image showing large, hyperechoic 
or polycystic kidneys is not characteristic of ADPKD and 
may be associated with other malformations of the urinary 
tract (simple renal cyst, cystic renal dysplasia), as well as 
with other degenerating polycystic kidney disorders (e.g. 
an autosomal recessive kidney disease ARPKD) or genetic 
Figure 1. Ultrasound image of fetal kidneys with ADPKD — frontal view
Figure 2. Magnetic resonance image of transvers view of mother 
kidneys and frontal view of fetal kidneys. Both, mother and fetus had 
ADPKD; M — mother kidney; F — fetal kidney
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30]. It was shown that the size of the kidney in children as 
well as in adults correlates with the severity of the disease. 
Enlarged kidneys in the first decade of life suggest a rapid 
development of extreme renal failure [35]. 
SUMMARY
Autosomal dominant polycystic kidney degeneration 
(ADPKD) is one of the most common hereditary kidney dis-
eases. It is estimated that an early onset of ADPKD applies up 
to 2% of patients. This birth defect is characterized by a wide 
diversity of clinical symptoms in individual patients. The 
clinical picture significantly differs not only among families, 
but also among members of one family. There are currently 
studies which aim to explain the exact genetic background. 
The advancement of prenatal ultrasonography led to more 
frequent diagnosis of intrauterine presentation of this disor-
der. Large hyperechoic kidneys found in ultrasound picture 
should lead to a suspicion of this disease. A positive family 
history and exclusion of other causes enables a proper di-
agnosis. Sometimes, it is necessary to preform diagnostic 
testing on parents. Magnetic resonance imaging can be 
utilized as a complementary diagnostic tool. The survival 
rate of children suffering from an early onset of ADPKD is 
relatively high, but they require multiple drug therapies for 
hypertension at an early age.
REFERENCES
1. Harris PC, Torres VE. Polycystic kidney disease. Ann Rev Med. 2009, 60, 
321–337.
2. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney 
disease. Lancet. 2007, 369, 1287–1301.
3. Sinibaldi D, Malena S, Mingarelli R, [et al.]. Prenatal ultrasonographic 
findings of dominant polycystic kidney disease and postnatal renal 
evolution. Am J Med Genet. 1996, 65, 337–341.
4. Friedmann W, Vogel M, Dimer JS, [et al.]. Perinatal differential diagnosis of 
cystic kidney disease and urinary tract obstruction: anatomic pathologic, 
ultrasonographic and genetic findings. Eur J Obstet Gynecol Reprod Biol. 
2000, 89, 127–133.
5. Bergmann C. ARPKD and early manifestations of ADPKD: the original 
polycystic kidney disease and phenocopies. Pediatr Nephrol. 2015, 30, 
15–30.
6. Hughes J, Ward CJ, Peral B, [et al.]. The polycystic kidney disease 1 
(PKD1) gene encodes a novel protein with multiple cell recognition 
domains. Nat. Genet. 1995, 10, 151–160.
7. Mochizuki T, Wu G, Hayashi T, [et al.]. PKD2, a gene for polycystic kidney 
disease that encodes an integral membrane protein. Science. 1996, 
272, 1339–1342.
8. Fick GM, Johnson AM, Strain JD, [et al.]. Characteristics of very early 
onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 
1993, 3, 1863–1870.
9. Chaumoitre K, Brun M, Cassart M, [et al.]. Differential diagnosis of fetal 
hyperechogenic cystic kidneys unrelated to renal tract anomalies: 
A multicenter study. Ultrasound Obstet Gynecol. 2006, 28, 911–917.
10. Hammond L, McKenna PH. Spontaneous neonatal regression of pre-
natally detected renal cysts in autosomal dominant polycystic kidney 
disease. J Urol. 2004, 171, 331–332.
11. Koptides M, Deltas CC. Autosomal dominant polycystic kidney disease: 
molecular genetics and molecular pathogenesis. Hum Genet. 2000, 
107, 115–126.
12. Rossetti S, Kubly VJ, Consugar MB, [et al.]. Incompletely penetrant PKD1 
alleles suggest a role for gene dosage in cyst initiation in polycystic 
kidney disease. Kidney Int. 2009, 75, 848–855.
tion) of water molecules in tissue. An affected organ will show 
a hyperintense image due to a failure of the diffusion processes 
[26, 27]. Chaumoitre analyzed the results of normal fetuses 
and of 10 fetuses affected by kidney pathology. In cases of 
renal polycystic disorders (both ARPKD and ADPKD), as in 
hydronephrosis, the images gave a hyperintensive signal [28].
PROGNOSIS
Genetic consultations are very difficult for this group of 
families, since very little is still known about the observation 
and progression of renal failure in children diagnosed in 
utero or showing symptoms of ADPKD in early childhood. 
The first reports stated that nearly half of all children with 
ADPKD die before the age of one [8, 29, 30]. However, recent 
reports have shown favorable prognosis for these children 
[31, 32]. Fick et al. described that out of 11 cases diagnosed 
prenatally: 8 showed a normal or near proper function of 
the kidneys in the childhood, 2 developed extreme kidney 
failure, and one fetus was subjected to termination [8]. In 
2001, Fick et al. published results of a fifteen-year follow-up 
of 312 patients whose major problem was drug-resistant 
hypertension [8, 33]. Children with early onset ADPKD often 
manifest hypertension, albuminuria, and renal failure. Devel-
oping albuminuria can be a predictor of disease severity [34]. 
Oligohydramnios occurring during pregnancy is consid-
ered to be a negative prognostic factor. There is no prognos-
tic significance in prenatal ultrasound based on: presence 
or absence of cysts, their size, number and location [28, 
Figure 3. Magnetic resonance image of fetus with ADPKD — sagittal view
608
Ginekologia Polska 2016, vol. 87, no. 8
www. journals.viamedica.pl/ginekologia_polska
13. Hopp K, Ward CJ, Hommerding CJ, [et al.]. Functional polycystin-1 dosage 
governs autosomal dominant polycystic kidney disease severity. J Clin 
Invest. 2012, 122, 4257–4273.
14. Vujic M, Heyer CM, Ars E, [et al.]. Incompletely penetrant PKD1 alleles mimic 
the renal manifestations of ARPKD. J Am Soc Nephrol. 2010, 21, 1097–1102.
15. Bergmann C, Bothmer J, Ortiz Brüchle N, [et al.]. Mutations in multiple 
PKD genes may explain early and severe polycystic kidney disease. J Am 
Soc Nephrol. 2011, 22, 2047–2056.
16. Bergmann C. Ciliopathies. Eur J Pediatr. 2012, 171, 1285–1300.
17. Tan YC, Blumenfeld J, Rennert H. Autosomal dominant polycystic kidney 
disease: genetics, mutations and microRNAs. Biochim Biophys Acta. 2011, 
1812, 1202–1212.
18. Brun M, Maugey-Laulom B, Eurin D, [et al.]. Prenatal sonographic patterns 
in autosomal dominant polycystic kidney disease: a multicenter study. 
Ultrasound Obstet Gynecol. 2004, 24, 55–61.
19. Sinibaldi D, Malena S, Mingarelli R, [et al.]. Prenatal ultrasonographic 
findings of dominant polycystic kidney disease and postnatal renal 
evolution. Am J Med Genet. 1996, 65, 337–341.
20. Journel H, Guyot C, Barc RM, [et al.]. Unexpected ultrasonographic 
prenatal diagnosis of autosomal dominant polycystic kidney disease. 
Prenat Diagn. 1989, 9, 663–671.
21. Michaud J, Russo P, Grignon A, [et al.]. Autosomal dominant polycystic 
kidney disease in the fetus. Am J Med Genet. 1994, 51, 240–246.
22. Jeffery S, Saggar-Malik AK, Econornides DL, [et al.]. Apparent normalisa-
tion of fetal renal size in autosomal dominant polycystic kidney disease 
[PKDl]. Clin Genet. 1998, 53, 303–307.
23. Chapman AB, Johnson AM, Gabow PA. Pregnancy outcome and its rela-
tionship to progression of renal failure in autosomal dominant polycystic 
kidney disease. J Am Soc Nephrol. 1994, 5, 1178–1185.
24. Abdelazim IA, Belal MM. The role of magnetic resonance imaging in 
refining the diagnosis of suspected fetal renal anomalies. J Turk Ger 
Gynecol Assoc. 2013, 14, 6–10.
25. Poutamo J, Vanninen R, Partanen K, [et al.]. Diagnosing fetal urinary tract 
abnormalities: benefits of MRI compared to ultrasonography. Acta Obstet 
Gynecol Scand. 2000, 79, 65–71.
26. Thoeny HC, De Keyzer F. Extracranial applications of diffusion-weighted 
magnetic resonance imaging. Eur Radiol. 2007, 17, 1385–1393.
27. Krawczyk R, Rytlewski J, Poniatowska R, [et al.]. Dyfuzyjne badanie 
metodą rezonansu magnetycznego-podstawy fizyczne i zastosowania 
kliniczne. Postępy Psychiatrii i Neurologii. 2005, 14, 47–56.
28. Chaumoitre K, Colavolpe N, Shojai R, [et al.]. Diffusion weighted mag-
netic resonance imaging with apparent diffusion coefficient (ADC) 
determination in normal and pathological fetal kidneys. Ultrasound 
Obstet Gynecol. 2007, 29, 22–31.
29. MacDermot KD, Saggar-Malik AK, Economides DL, [et al.]. Prenatal 
diagnosis of autosomal dominant polycystic kidney disease (PKD 1) 
presenting in utero and prognosis for very early onset disease. J Med 
Genet. 1998, 35, 13–16.
30. Winyard P, Chitty L. Dysplastic and polycystic kidneys: diagnosis, associa-
tions and management. Prenat Diagn. 2001, 21, 924–935.
31. Boyer O, Gagnadoux MF, Guest G, [et al.]. Prognosis of autosomal domi-
nant polycystic kidney disease diagnosed in utero or at birth. Pediatr 
Nephrol. 2007, 22, 380–388.
32. Zerres K, Rudnik-Schoneborn S, Deget F. Childhood onset autosomal 
dominant polycystic kidney disease in sibs: clinical picture and recur-
rence risk. J Med Genet. 1993, 30, 583–588.
33. Fick-Brosnahan GM, Tran ZV, Johnson AM, [et al.]. Progression of 
autosomal-dominant polycystic kidney disease in children. Kidney Int. 
2001, 59, 1654–1662.
34. Selistre L, de Souza V, Ranchin B, [et al.]. Early renal abnormalities in 
children with postnatally diagnosed autosomal dominant polycystic 
kidney disease. Pediatr Nephrol. 2012, 27, 1589–1593.
35. C, Torra R, Bianchi L, [et al.]. Abdominal sonographic study of autosomal 
dominant polycystic kidney disease. J Clin Ultrasound. 2000, 28, 277–282.
